Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Major Vendor (Details)

v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Major Vendor (Details) - Supplier Concentration Risk - Vendor One
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Research and development expenditures          
Concentration          
Concentration Risk (as a percent) 75.00% 25.00% 70.00% 36.00%  
Accounts payable and accrued expense          
Concentration          
Concentration Risk (as a percent)     88.00%   56.00%